Cure 250 Children with Burkitt Lymphoma in Africa

by The International Network for Cancer Treatment and Research (INCTR)
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Cure 250 Children with Burkitt Lymphoma in Africa
Nov 15, 2017

Anthony Has a Reason to Smile

Anthony Awaiting Discharge after Treatment
Anthony Awaiting Discharge after Treatment

In December of 2016, Anthony came to our hospital, St Mary’s Hospital Lacor in Gulu, Uganda. He was 11 years old.  Anthony is from the Moyo District in the north eastern part of the country and he lives over 100 kilometers from Gulu.  His father is raising Anthony and his two brothers – one brother is Anthony’s twin – as a single parent.  When Anthony arrived on our Burkitt’s ward, he presented with swelling of his abdomen which had been rapidly progressing for one month.  His abdominal swelling was associated with pain and he also had fevers during the night that were followed by sweating.  When we examined him, he had a distended abdomen and we could easily palpate or feel masses within his abdomen.  He also had involvement of his spleen.  But, he was able to walk in spite of his painful and distended abdomen.  And, Anthony was actually able to give us most of the history of his illness.  He underwent a biopsy in order to diagnose what we suspected was Burkitt lymphoma (BL).

Once we received confirmation of Anthony’s diagnosis as being BL, he was started on treatment right away. He developed a common side effect of chemotherapy called neutropenia which means that his infection fighting white blood cells in his body were too low. Therefore, he was at risk of acquiring a serious infection that might potentially result in the loss of his life.  His next cycle of chemotherapy had to be delayed in order to allow his bone marrow which makes these important blood cells to recover.  But, Anthony was strong and he managed to get through this period of neutropenia despite our own limited resources to protect him against life-threatening infections.  Although he received a second cycle of our first line therapy without any side effects, an evaluation of his disease status showed that he was not responding to treatment as we had hoped. 

Therefore, we made the decision to change him to the second line therapy that consists of drugs that are considered to be non-cross resistant (and different) to those chemotherapy drugs he had received during his first two cycles. The drugs used in the second line therapy are also highly effective against BL when our first line therapy does not work as well as we expect it to.  With the ability to provide the second line therapy, we were able to offer Anthony and his family hope.  The second line therapy has more drugs with the potential to cause more harmful side effects.  To our joy, Anthony completed all of the four planned second line treatment cycles without major side effects.  But, most importantly, he had a complete resolution of his BL. 

Anthony comes for regular follow up visits. I saw him recently and he was very happy and healthy.  His life is normal again, he is with his family and he cannot wait to go back to school as soon as the new term begins.  His smile said it all – “thank you, thank everyone and every kind heart that gives to save lives like mine and many of the children with Burkitt Lymphoma”.

Share on Twitter Share on Facebook
Comments:

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Project Leader:
Melissa Adde
Brussels, Brussels Belgium
$118,163 raised of $125,000 goal
 
924 donations
$6,837 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

The International Network for Cancer Treatment and Research (INCTR) has earned this recognition on GlobalGiving:

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.